Bio-Rad Extends Range of Anti-Idiotypic Antibodies for Bioanalysis and Drug Monitoring
Hercules, Calif - Bio-Rad Laboratories, Inc, a global leader in life science research and clinical diagnostic products, extends its range of recombinant monoclonal anti-idiotypic antibodies with the introduction of antibodies specific to brentuximab vedotin (Adcetris), secukinumab (Cosentyx), and the secukinumab–interleukin 17A (IL-17A) drug-target complex. These sequence-defined antibodies are…
Centauri Therapeutics strengthens senior leadership team with three key appointments
Centauri Therapeutics Limited (Centauri), an immunotherapy company focused on the treatment of infectious diseases, today announced three senior appointments: Dr Jennifer Schneider as Chief Executive Officer (CEO), Dr Helen Bright as Vice President (VP) of Research & Development (R&D), and Professor David Roblin FRCP FMedSci as Chair of the Board of Directors.
Ubiquigent appoints Professor Helen Walden and Professor John Davis to Scientific Advisory Board
Experts in structural biology and drug development will help exploit the deubiquitylase (DUB) enzyme family as new drug targets
Mogrify and Astellas announce collaboration to conduct research on in vivo regenerative medicine approaches to address sensorineural hearing loss
Mogrify Limited, a biopharmaceutical company transforming the lives of patients through a novel class of in vivo reprogramming therapies, and Astellas Pharma Inc., a leader in regenerative medicine, today announced that they have executed a collaborative research agreement on in vivo regenerative medicine approaches to address sensorineural hearing loss.
LG Chem renews license triggering payment to Avacta
LG Chem will now proceed with Investigational New Drug (IND) enabling studies for Affimer PD-L1 antagonist programme
Avacta announces second dose escalation in the Phase I clinical study of AVA6000 Pro-doxorubicin
Avacta Group plc (AIM: AVCT), a clinical stage oncology drug company and developer of powerful diagnostics based on its innovative Affimer® and pre|CISION™ platforms, announces that the first-in-human Phase I trial (ALS-6000-101) of AVA6000 Pro-doxorubicin will advance to the third dose cohort following a positive review of the safety data from the dosing of the second cohort.
Bio-Rad launches EconoFit Chromatography Column Packs
HERCULES, Calif.— Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products, announces the launch of EconoFit Low-Pressure Prepacked Chromatography Column Packs to support resin screening experiments in the development of protein purification workflows.
H.E.L Group releases iso-BTC+ calorimeter for isothermal battery performance testing
H.E.L Group (H.E.L), a global developer and manufacturer of innovative laboratory tools for process optimization, safety, and scale-up, announces the release of iso-BTC+, the latest addition to its battery testing portfolio.
Bio-Rad introduces CFX Opus Deepwell Real-Time PCR Detection System
Hercules, Calif. — Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products, announces the launch of the CFX Opus Deepwell Real-Time PCR Detection System to support researchers in developing nucleic acid detection assays.
FUJIFILM Irvine Scientific acquires exclusive license for artificial intelligence for IVF
Santa Ana, Calif., FUJIFILM Irvine Scientific, Inc., a world leader in the innovation, development, and manufacture of cell culture media and assisted reproductive technologies (ART), announces it has exclusively licensed the intellectual property relating to artificial intelligence (AI) for image-based evaluation of human embryos to improve in-vitro fertilization (IVF) success rates
Optibrium receives further investment from Kester Capital
Cambridge UK - Optibrium™, a developer of software for drug discovery, announces it has secured further investment from existing investors Kester Capital, a leading UK mid-market private equity firm.
Yourgene Health Launches LightBench Detect for Fetal Fraction Enrichment
Manchester, UK - Yourgene Health plc, a leading international molecular diagnostics group, announces the launch of the LightBench® Detect, the latest addition to its Ranger® Technology instrumentation portfolio at the 26th International Conference on Prenatal Diagnosis and Therapy (ISPD).
Global Access Diagnostics (GADx) formed to expand affordable access to advanced rapid diagnostic technologies
Bedford, UK - Global Access Health (GAH), a social enterprise dedicated to providing affordable medical products for global health, formally introduces its first portfolio company, Global Access Diagnostics (GADx). GADx has been created to address gaps in the global provision of diagnostics with a focus on expanding affordable access to quality tests.
seqWell appoints Dr Amy Liao to Board of Directors
Beverly, Mass – seqWell, a global provider of genomic library workflow solutions including the plexWell™ next-generation sequencing (NGS) multiplexing technology, announces the appointment of Dr Amy Liao to its Board. Amy joins the current Board of Directors, led by Chairman Paul McEwan. The appointment supports the commercial development of the Company’s existing and future products, following…
Spirea raises £2.4M ($3M) to develop antibody drug conjugates in cancer
Cambridge - Spirea Limited, a Cambridge company created to advance a new generation of antibody drug conjugate (ADC) therapeutics, has announced that it has secured funding of £2.4 million with investments from high-profile UK and US investors. Spirea will use the funds to initiate its pipeline of superior and differentiated ADCs in the treatment of solid tumours where there is a high unmet need.
Bio-Rad Launches Foresight Pro Columns for Biotherapeutic Production
Helcules, Calif. - Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, announces the launch of its CHT™ prepacked Foresight Pro Columns, designed to support downstream process-scale chromatography applications across different stages of biological drug development and production.
Innovate UK awards grant to Orbit Discovery to expand high throughput cell-based functional screening platform capabilities in peptide drug discovery
The project will use microfluidic technology to improve efficiency of peptide therapeutics discovery for challenging drug targets.
Metrion Biosciences appoints Dr Benedetta Montagnini as Head of European Business Development
Expansion of European business development team supports next phase of growth for Metrion’s ion channel drug discovery services
Optibrium expands UK head office with new facilities on Cambridge Innovation Park
Optibrium™, a developer of software for drug discovery, announces the expansion of its UK headquarters with a move to larger office premises on Cambridge Innovation Park North. The new facilities accommodate Optibrium's accelerated growth and ongoing recruitment efforts to support the continued success and development of the company's innovative technology focused on improving the efficiency and…
Bio-Rad Launches SEQuoia Express Stranded RNA Library Prep Kit at AGBT 2022
Hercules, Calif. — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, announces the launch of the SEQuoia Express Stranded RNA Library Prep Kit. The kit provides biopharmaceutical and research scientists with an easy-to-use solution for constructing robust libraries to support efficient RNA-Seq workflows for comprehensive…
Dotmatics strengthens leadership team as it continues to invest in organization capabilities and accelerate growth
Dotmatics, the leader in R&D scientific software connecting science, data, and decision-making, announces the addition of Larry Samuelson as Chief Legal Officer and Neil Frye as Chief People Officer. The appointments further bolster the company’s executive team as the company extends the reach of its research and data solutions globally.
seqWell and Element Biosciences partner to demonstrate sequencing performance of multiplexed plexWell technology with the AVITI System
Beverly, Mass. And San Diego, Calif., - seqWell, a global provider of genomic library workflow solutions including the plexWell™ next-generation sequencing (NGS) multiplexing technology, announces a partnership with Element Biosciences Inc., developer of the Element AVITI™ System.
Bio-Rad launches CFX Duet Real-Time PCR System
Hercules, Calif. – Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, announces the launch of the CFX Duet Real-Time PCR System to support researchers in developing singleplex and duplex quantitative PCR (qPCR) assays.
CN Bio appoints Dr Paul Brooks as Chief Business Officer
Cambridge, UK : CN Bio, a leading Organ-on-a-chip Company (OOC) that designs and manufactures single- and multi-organ microphysiological systems (MPS), announces the appointment of Dr Paul Brooks as Chief Business Officer.
FUJIFILM Irvine Scientific completes construction of Bioprocessing Innovation and Collaboration Center in China
New center opens in Suzhou New District, China, to bring local cell culture media optimization support for vaccines, advanced therapies, and biotherapeutic drug development.